Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP

Blood (2019) 134 (Supplement_1): 921.

https://doi.org/10.1182/blood-2019-127399

Published: 2019

Journal Articles

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Gerben Duns, PhD, Elena Viganò, PhD, Daisuke Ennishi, MD PhD, Clementine Sarkozy, MD, Stacy Hung, Elizabeth Chavez, Katsuyoshi Takata, MD PhD, Anja Mottok, MD PhD, Randy D. Gascoyne, MD, Ryan D. Morin, PhD, Kerry J Savage, BSc, MD MSc, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 922.

https://doi.org/10.1182/blood-2019-131450

Published: 2019

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Anca Prica, MD, Ryan D. Morin, PhD, Vishal Kukreti, MD, Robert Kridel, MDMPH,PhD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, Miguel Alcaide, Rashmi S. Goswami, MD PhD, Jan Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, MBChB, PhD, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 2027.

https://doi.org/10.1182/blood-2019-131818

Published: 2019

Journal Articles

NFKBIZ 3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma

Sarah E Arthur, BSc, Nicole Thomas, BSc, Christopher Rushton, BSc, Miguel Alcaide, PhD, Shannon Healy, PhD, Anja Mottok, MD PhD, David W. Scott, MBChB, PhD, Christian Steidl, MD, Ryan D. Morin, PhD

Blood (2019) 134 (Supplement_1): 296.

https://doi.org/10.1182/blood-2019-127421

Published: 2019

Journal Articles

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Pedro Farinha, MD PhD, Daisuke Ennishi, MD PhD, Anja Mottok, MD PhD, Susana Ben-Neriah, BSc, Barbara Meissner, PhD, Merrill Boyle, BSc, Jeffrey W. Craig, MD PhD, Graham W Slack, MD, Diego Villa, MD MPH, Kerry J Savage, BSc, MD MSc, Laurie H Sehn, MD, Ryan D. Morin, PhD, Marco A. Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 3964.

https://doi.org/10.1182/blood-2019-121943

Published: 2019

Journal Articles

Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1478.

https://doi.org/10.1182/blood-2019-129136

Published: 2019

Journal Articles

CD20 Is an Unstable Target in Primary-Refractory High-Grade Lymphomas

Ryan N Rys, BSc, BA, Dominique Geoffrion, BSc, Christopher Rushton, BSc, Miguel Alcaide, PhD, Raoul Santiago, MDMSc, Koren Kathleen Mann, PhD, Svetlana Dmitrienko, MD PhD, Tina Petrogiannis-Haliotis, MD PhD, Sarit Assouline, MD, Ryan D. Morin, PhD, Nathalie Johnson, MD

Blood (2019) 134 (Supplement_1): 1608.

https://doi.org/10.1182/blood-2019-127129

Published: 2019

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Ryan D. Morin, PhD BSc, MSc, Anca Prica, MD, Vishal Kukreti, MD, Robert Kridel, PhD MD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, BSc, Miguel Alcaide, PhD, Rashmi S. Goswami, BSc, MD PhD FRCPC, Jan M.A. Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, PhD MD, FRACP, FRCPA, John Kuruvilla, MD

Blood (2018) 132 (Supplement 1): 4610.

https://doi.org/10.1182/blood-2018-99-117333

Published: 2018

Journal Articles

UBR5 Mutations in Mantle Cell Lymphoma Lead to Increased Proliferation through a Cyclin D1-Dependent Mechanism

Olga Kutovaya, PhD, Stacy Hung, Elena Viganò, PhD, Adele Telenius, Bruce W Woolcock, Barbara Meissner, PhD, Shane Colborne, BSc, Randy D. Gascoyne, MD, Diego Villa, MD, Ryan D. Morin, PhD, BSc, MSc, David W. Scott, PhD MD, FRACP, FRCPA, Gregg B Morin, PhD, Christian Steidl, MD

Blood (2018) 132 (Supplement 1): 2849.

https://doi.org/10.1182/blood-2018-99-118524

Published: 2018

Journal Articles

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 1560.

https://doi.org/10.1182/blood-2018-99-112010

Published: 2018

Journal Articles

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Christoffer Hoffer, Hennady Shulha, Anja Mottok, MD, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Ryan D Morin, PhD, Marco A. Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Joseph M Connors, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 703.

https://doi.org/10.1182/blood.V124.21.703.703

Published: 2014

Journal Articles

FAS Mutations Accelerate Lymphoma Growth and Induce Therapeutic Resistance

Stephanie Totten, B.Sc., Denis Gaucher, PhD, Ryan D Morin, PhD, Sarit Assouline, MD MSc, Joseph M. Connors, MD, Marco A. Marra, PhD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD, Jerry Pelletier, PhD, Koren K Mann, PhD, Nathalie Johnson, MD PhD

Blood (2014) 124 (21): 3018.

https://doi.org/10.1182/blood.V124.21.3018.3018

Published: 2014

Journal Articles

Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation

Fong Chun Chan, MSc, Susana Ben-Neriah, Raymond Lim, MSc, Sandy Hu, Sanja Rogic, PhD, Nathalie Johnson, MD, Ryan D Morin, PhD, Gavin Ha, Jiraui Ding, MSc, David W. Scott, MBChB PhD, Laurie H. Sehn, MD, Joseph M. Connors, MD, Marco A. Marra, PhD, Randy D. Gascoyne, MD, Sohrab P Shah, PhD, Christian Steidl, MD

Blood (2012) 120 (21): 295.

https://doi.org/10.1182/blood.V120.21.295.295

Published: 2012

Journal Articles

FAS Mutations Are Associated with Therapeutic Resistance in Follicular Lymphoma

Nathalie Johnson, MD, PhD, Denis Gaucher, PhD, Hawley Rigsby, Ryan D Morin, PhD, Joseph M. Connors, MD, Marco Marra, PhD, Randy D. Gascoyne, MD

Blood (2012) 120 (21): 1549.

https://doi.org/10.1182/blood.V120.21.1549.1549

Published: 2012

NARROW

Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP

Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

NFKBIZ 3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma

CD20 Is an Unstable Target in Primary-Refractory High-Grade Lymphomas

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

UBR5 Mutations in Mantle Cell Lymphoma Lead to Increased Proliferation through a Cyclin D1-Dependent Mechanism

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

FAS Mutations Accelerate Lymphoma Growth and Induce Therapeutic Resistance

Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation

FAS Mutations Are Associated with Therapeutic Resistance in Follicular Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only